Sharpe C, Reiner GE, Davis SL, et al; FOR THE NEOLEV2 INVESTIGATORS. Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial. Pediatrics. 2020;145(6):e20193182
- PMID: 33384298
- PMCID: PMC8190963
- DOI: 10.1542/peds.2020-036806
Sharpe C, Reiner GE, Davis SL, et al; FOR THE NEOLEV2 INVESTIGATORS. Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial. Pediatrics. 2020;145(6):e20193182
Erratum for
-
Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial.Pediatrics. 2020 Jun;145(6):e20193182. doi: 10.1542/peds.2019-3182. Epub 2020 May 8. Pediatrics. 2020. PMID: 32385134 Free PMC article. Clinical Trial.
Comment in
-
Randomized Controlled Trial Evaluating Levetiracetam as First-line Therapy for Seizures in Neonates: Evidence-based Medicine Viewpoint.Indian Pediatr. 2020 Sep 15;57(9):848-851. Indian Pediatr. 2020. PMID: 32999112 No abstract available.
-
Randomized Controlled Trial Evaluating Levetiracetam as First-line Therapy for Seizures in Neonates: Pediatric Neurologist's Viewpoint.Indian Pediatr. 2020 Sep 15;57(9):851-852. Indian Pediatr. 2020. PMID: 32999113 No abstract available.
-
Randomized Controlled Trial Evaluating Levetiracetam as First-line Therapy for Seizures in Neonates: Neonatologist's Viewpoint.Indian Pediatr. 2020 Sep 15;57(9):852-853. Indian Pediatr. 2020. PMID: 32999114 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources